Fonte: Abstracts. Nome do evento: ISoP Annual Meeting "A New Era of Pharmacovigilance: Challenges and Opportunities". Unidade: FCF
Assuntos: NEOPLASIAS DO TRATO RESPIRATÓRIO, GENÓTIPOS, VARIAÇÃO GENÉTICA
ABNT
MORIEL, Patricia et al. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. 2022, Anais.. London: International Society of Pharmacovigilance/ISOP, 2022. . Acesso em: 26 ago. 2024.APA
Moriel, P., Morau, M. V., Seguin, C. M., Barbeiro, A. D. S., Zambon, L. M., Pincinato, E. de C., et al. (2022). ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. In Abstracts. London: International Society of Pharmacovigilance/ISOP.NLM
Moriel P, Morau MV, Seguin CM, Barbeiro ADS, Zambon LM, Pincinato E de C, Perroud Junior MW, Visacri MB. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. Abstracts. 2022 ;[citado 2024 ago. 26 ]Vancouver
Moriel P, Morau MV, Seguin CM, Barbeiro ADS, Zambon LM, Pincinato E de C, Perroud Junior MW, Visacri MB. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. Abstracts. 2022 ;[citado 2024 ago. 26 ]